BDSX — BIODESIX INC
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1439725 ·
Last close
$29.10
Market Cap
$307.04M
52W High
$31.35
52W Low
$5.26
ADV30
111,050
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 26,861,000 | 22,041,000 | -5,376,000 | -7,273,000 | 95,326,000 | 29,996,000 | 86,182,000 |
| Mar 2026 | 25,555,000 | 21,350,000 | -6,196,000 | -7,793,000 | 94,637,000 | 25,572,000 | 85,505,000 |
| Dec 2025 | 28,755,000 | 23,876,000 | -1,966,000 | -3,980,000 | 87,476,000 | 18,987,000 | 89,941,000 |
| Sep 2025 | 21,768,000 | 17,662,000 | -7,044,000 | -8,716,000 | 88,722,000 | 16,604,000 | 90,444,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-19,831,000
Investing CF
$-569,000
Financing CF
$29,668,000
CapEx
$-569,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.17
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-512,828,000
Inventory
—
Receivables
$9,113,000
ST Investments
—
EBIT TTM
$-19,670,000
Pretax Income TTM
$-27,762,000
Interest Exp TTM
$8,092,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$102,939,000
EBITDA
$-15,005,000
Free Cash Flow
$-10,889,250
Enterprise Value
$326,310,912
Total Cash
$29,996,000
Total Debt
$71,796,000
Shares Out
10,551,118
Trailing EPS
$-3.10
Book Value
$0.87
ROE
-540.0%
ROA
-14.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 88,499,000 | -27,766,000 | -35,265,000 | 87,476,000 | 89,941,000 | -2,465,000 | -23,271,000 |
| Dec 2024 | 71,323,000 | -34,260,000 | -42,931,000 | 97,244,000 | 76,368,000 | 20,876,000 | -48,649,000 |
| Dec 2023 | 49,087,000 | -41,298,000 | -52,146,000 | 99,096,000 | 94,516,000 | 4,580,000 | -22,870,000 |
| Dec 2022 | 38,212,000 | -50,506,000 | -65,447,000 | 92,906,000 | 72,300,000 | 20,606,000 | -44,972,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.22
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VMD | VIEMED HEALTHCARE, INC. | $339.37M | $8.91 | — |
| YDES | YD Bio Ltd | $405.86M | $5.73 | — |
| CYH | COMMUNITY HEALTH SYSTEMS INC | $414.57M | $2.94 | — |
| DFPH | Starling Oncology, Inc. | $436.37M | $2.01 | — |
| MCTA | Charming Medical Ltd | $445.55M | $29.35 | — |
News headlines (Yahoo Finance, 1h cache)
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
2026-09-28 14:03 · Yahoo
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher
2026-09-24 10:34 · Yahoo
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
2026-09-24 10:00 · Yahoo
Biodesix to Participate in Upcoming Investor Conferences
2026-09-03 10:00 · Yahoo
What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now?
2026-08-31 16:00 · Yahoo
Wall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High?
2026-08-31 13:55 · Yahoo
Biodesix (BDSX) Q2 2026 Earnings Call Transcript
2026-08-12 21:59 · Yahoo
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference
2026-08-12 21:04 · Yahoo
Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue?
2026-08-11 13:15 · Yahoo
Biodesix Inc (BDSX) (Q2 2026) Earnings Call Highlights: Revenue Surges 34% on Strong Diagnostic ...
2026-08-06 05:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.